Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?-Reference-Cited by-同舟云学术

Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?

Published:2016-12-23 Issue:3 Volume:96 Page:363-371
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Paubelle Etienne,Ducastelle-Leprêtre Sophie,Labussière-Wallet Hélène,Nicolini Franck Emmanuel,Barraco Fiorenza,Plesa Adriana,Salles Gilles,Wattel Eric,Thomas Xavier

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-016-2899-0.pdf

Reference42 articles.

1. Kell J (2016) Considerations and challenges for patients with refractory and relapsed acute myeloid leukaemia. Leuk Res 47:149–160

2. Estey E, Kornblau S, Pierce S et al (1996) A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemia. Blood 88:756

3. Estey EH (2000) Treatment of relapsed and refractory acute myelogenous leukemia. Leukemia 14:476–479

4. Breems DA, Van Putten WL, Huijgens PC et al (2005) Prognostic index for adult patients with acute myeloid leukemia in first relapse. J Clin Oncol 23:1969–1978

5. Fiegl M, Unterhalt M, Kern W et al (2014) Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG. Leukemia 28:1001–1007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gemtuzumab Ozogamicin Monotherapy Is a Well-tolerated Palliative Chemotherapy Option in Pediatric Multiply Relapsed Acute Myeloid Leukemia: A Multicenter Case Series and Review of the Literature;Journal of Pediatric Hematology/Oncology;2023-10-09

2. The Use of Gemtuzumab Ozogamicin as Salvage Therapy in Patients with Acute Myeloid Leukemia: A Monocentric Real-World Experience;Medicina;2023-03-02

3. Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin;Cancers;2021-09-11

4. Does the order of busulfan and cyclophosphamide affect allogeneic stem cell transplantation related liver toxicity?;Annals of Hematology;2021-03-10

5. Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia;Bone Marrow Transplantation;2021-02-09